I’m a Pathologist. Ozempic & Mounjaro Aren’t Actually Weight Loss Drugs.



Ozempic and Mounjaro aren’t actually weight loss drugs. I’m a pathologist, and I’m going to show you what these GLP-1 medications actually do inside your body, and the one thing that decides whether they change your life or quietly set you up to end up worse than where you started.
In 2005, the FDA approved a diabetes drug. Then something nobody planned for happened. Hearts got stronger. Kidneys healed. Sleep apnea reversed. Women with PMOS (formerly called PCOS) started ovulating again. One class of drugs, doing things that on the surface have nothing to do with each other. For 20 years, that mystery didn’t have a clean answer. It does now.
I’m Dr. Amin Hedayat, triple board-certified physician and medical school assistant clinical professor. In this video I break down what Ozempic, Mounjaro, Wegovy, Foundayo and Zepbound actually do at the cellular level, why the miracle crowd and the poison crowd are both wrong, and the bridge framework that decides whether these drugs work for you or backfire.

What you’ll learn:
✅ Why GLP-1 was never really a blood sugar drug
✅ The clue from the SELECT trial that broke the case open
✅ 3 silent habits killing your body’s natural GLP-1 signal
✅ The honest truth about muscle loss, cancer risk, and side effects
✅ 5 foundations that decide whether your results last
✅ What the FLOW kidney trial and the 2024 sleep apnea data show
━━━━━━━━━━━━━━━━━━━━━━━━━━━━
🎯 JOIN THE GET UNINFLAMED INNER CIRCLE WAITLIST Doors open July 1st. Waitlist members get first access and founding-member pricing. This is where I teach the foundations in practical, day-to-day actions: how to build meals that wake up your own GLP-1, how to protect your muscle, and how to walk into your doctor’s office prepared.
👉 Join the waitlist:

📥 FREE DOWNLOAD: The GLP-1 Companion The exact framework I think every patient should walk into a GLP-1 conversation with. What to ask, what to track, what to watch for.
👉 Download free: ━━━━━━━━━━━━━━━━━━━━━━━━━━━━ ⏱️ CHAPTERS 00:00 The Mystery (Cold Open) 02:16 Where the Drug Came From 04:13 The Clue Everyone Missed 04:58 The Real Answer: A Master Signal 06:45 Why the Signal Goes Quiet 07:10 The Bridge 09:54 Two Myths 14:03 The Five Foundations 17:25 The Bigger Picture (One Fire, Many Rooms) 18:40 What the Evidence Actually Shows 20:46 Inner Circle and Close
━━━━━━━━━━━━━━━━━━━━━━━━━━━━
📚 REFERENCES

Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. DOI: 10.1056/NEJMoa2307563

Perkovic V, Tuttle KR, Rossing P, et al. Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes. N Engl J Med. 2024;391(2):109-121. DOI: 10.1056/NEJMoa2403347

Malhotra A, Grunstein RR, Fietze I, et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. N Engl J Med. 2024;391(13):1193-1205. DOI: 10.1056/NEJMoa2404881

Zhou L, Qu H, Yang L, Shou L. Effects of GLP1RAs on pregnancy rate and menstrual cyclicity in women with polycystic ovary syndrome: a meta-analysis and systematic review. BMC Endocr Disord. 2023;23(1):245. DOI: 10.1186/s12902-023-01500-5

Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. DOI: 10.1056/NEJMoa2032183

Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. DOI: 10.1056/NEJMoa2206038

Kosiborod MN, Abildstrøm SZ, Borlaug BA, et al. Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity. N Engl J Med. 2023;389(12):1069-1084. DOI: 10.1056/NEJMoa2306963

Sanyal AJ, Newsome PN, Kliers I, et al. Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis. N Engl J Med. 2025;392(21):2089-2099. DOI: 10.1056/NEJMoa2413258

━━━━━━━━━━━━━━━━━━━━━━━━━━━━
📺 SUBSCRIBE for weekly evidence-based metabolic health videos: @draminhedayat
🔗 CONNECT
Instagram: @draminhedayat
Website:
website:

⚕️ MEDICAL DISCLAIMER
This video is general medical education, not personal medical advice. Decisions about GLP-1 medications, dosing, and treatment belong with your own physician. No financial disclosures. Dr. Hedayat is NOT directly or indirectly affiliated with a pharmaceutical company.

#Ozempic #Mounjaro #Wegovy #Zepbound #Semaglutide #Tirzepatide #GLP1 #WeightLoss #MetabolicHealth #InsulinResistance #SleepApnea #Type2Diabetes #DoctorExplains #GetUninflamed #Uninflamed

source

22 Comments

  1. Of the five foundations, which is the one you already know you've been skipping? Protein, lifting, sleep, food, or tracking. One word.

    Fewer than 4% of the people watching this are subscribed. I read every answer here and the most-requested one becomes the next deep dive, so subscribing is how you see it when it lands.

    I have no financial ties to any pharmaceutical company, compounding pharmacy, or peptide seller. I'm an independent educator.

    Free GLP-1 Companion, the one-pager to bring to your doctor: https://www.draminhedayat.com/glp1_companion

  2. This was very informative. My family is not supportive. They think I’m killing myself by doing this not realizing that my markers and bloodwork are excellent. My cholesterol has completely gotten better my triglycerides. I had a stent put in a year ago. I’ve lost at least 25 pounds I feel so much better. I struggle with the hair loss but I do have a lot of hair. Praise God I’m trying to eat more protein and change my eating habits to a Mediterranean style diet. I plan on doing this medication as a maintenance drug because the inflammation and everything has been so much better. I see the good in the drug, but I do see where it could be bad. I do not want to gain the weight back and I wanna keep feeling well. I’m just tired of fighting everyone about it. They scare me half to death making me feel like in the long run I may die because of this drug that it’s not safe. I would love to know your response.

  3. To answer your question: weight loss. Because they lose weight they receive the associated health benefits. It's not some miracle, it's just common sense. 💯

  4. Very good explanation and analogy. I have had so many work colleagues buy and use these medications without the understanding and support they are now on second or third times and eating less and less, struggle with nausea, taking more each time as they work less effectively. I have tried saying to them that they need to eat healthily as they are risking being nutrient deficient with the lack of food and nutrient intake. People still eating endless packets of crisps and sweeties. No idea of what they are stacking up for the future.

  5. Video sponsored by Novo Nordisk… Ozempic (semaglutide) carries serious risks including a boxed warning for potential thyroid C-cell tumors, as well as pancreatitis, gallbladder disease, severe gastrointestinal side effects, kidney problems, and other complications, and should only be used under close medical supervision after carefully weighing these dangers against any potential benefits.

Leave a Reply

Your email address will not be published. Required fields are marked *

You might like

© 2026 Cantinho do Vídeo - WordPress Video Theme by WPEnjoy